Differences in the immunogenicity of heterologous Ad26.COV.2/BNT162b2 vaccination compared to other heterologous and homologous COVID-19 vaccine regimens

被引：0
|
作者：
Klemis, V. [1 ]
Venhorst, A. [2 ]
Halmans, L. [2 ]
Schmidt, T. [1 ]
Greiss, F. [3 ]
Wilhelm, A. [4 ]
Widera, M. [4 ]
Sester, U. [5 ]
Gaertner, B. C. [6 ]
Meyer, T. [2 ]
Sester, M. [1 ]
机构：
[1] Saarland Univ, Dept Transplant & Infect Immunol, Homburg, Germany
[2] Saarland Univ, Inst Sports & Prevent Med, Saarbrucken, Germany
[3] Humboldt Univ, Dept Sports Med, Berlin, Germany
[4] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany
[5] SHG Klinikum Volklingen, Dept Nephrol, Volklingen, Germany
[6] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 019
引用
收藏
页码：165 / 166
页数：2
相关论文
共 50 条
  • [1] Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months
    Low, Ee Vien
    Tok, Peter Seah Keng
    Husin, Masliyana
    Suah, Jing Lian
    Tng, Boon Hwa
    Thevananthan, Thevesh
    Appannan, Maheshwara Rao
    Yahaya, Hazlina
    Zin, Shahanizan Mohd
    Zin, Faizah Muhamad
    Sivasampu, Sheamini
    Peariasamy, Kalaiarasu M.
    JAMA NETWORK OPEN, 2022, 5 (08) : E2226046
  • [2] Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
    Hu, Yuxuan
    Wang, Yanning
    Shao, Taihang
    Tang, Wenxi
    Hu, Kerong
    Zhou, Yujie
    Miao, Liyun
    Liu, Jing
    Wang, Bin
    Yu, Wenying
    VACCINE, 2023, 41 (18) : 3003 - 3010
  • [3] Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
    Klemis, Verena
    Schmidt, Tina
    Schub, David
    Mihm, Janine
    Marx, Stefanie
    Abu-Omar, Amina
    Ziegler, Laura
    Hielscher, Franziska
    Guckelmus, Candida
    Urschel, Rebecca
    Wagenpfeil, Stefan
    Schneitler, Sophie
    Becker, Soeren L.
    Gaertner, Barbara C.
    Sester, Urban
    Sester, Martina
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
    Reiter, Rieke
    Von Blanckenburg, Pia
    Mutters, Reinier
    Thiemer, Julia
    Gessner, Reinhard
    Seifart, Ulf
    VACCINES, 2022, 10 (05)
  • [5] Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
    Verena Klemis
    Tina Schmidt
    David Schub
    Janine Mihm
    Stefanie Marx
    Amina Abu-Omar
    Laura Ziegler
    Franziska Hielscher
    Candida Guckelmus
    Rebecca Urschel
    Stefan Wagenpfeil
    Sophie Schneitler
    Sören L. Becker
    Barbara C. Gärtner
    Urban Sester
    Martina Sester
    Nature Communications, 13
  • [6] Immunogenicity and efficacy of          heterologous ChAdOx1–BNT162b2 vaccination
    Bruno Pozzetto
    Vincent Legros
    Sophia Djebali
    Véronique Barateau
    Nicolas Guibert
    Marine Villard
    Loïc Peyrot
    Omran Allatif
    Jean-Baptiste Fassier
    Amélie Massardier-Pilonchéry
    Karen Brengel-Pesce
    Melyssa Yaugel-Novoa
    Solène Denolly
    Bertrand Boson
    Thomas Bourlet
    Antonin Bal
    Martine Valette
    Thibault Andrieu
    Bruno Lina
    François-Loïc Cosset
    Stéphane Paul
    Thierry Defrance
    Jacqueline Marvel
    Thierry Walzer
    Sophie Trouillet-Assant
    Nature, 2021, 600 : 701 - 706
  • [7] CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (05): : 255 - 255
  • [8] Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
    Botton, Jeremie
    Semenzato, Laura
    Jabagi, Marie-Joelle
    Baricault, Berangere
    Weill, Alain
    Dray-Spira, Rosemary
    Zureik, Mahmoud
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [9] Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
    Kim, Dong-In
    Lee, Seo Jin
    Park, Soonju
    Kim, Paul
    Lee, Sun Min
    Lee, Nakyung
    Shum, David
    Kim, Dong Ho
    Kim, Eui Ho
    VACCINES, 2022, 10 (11)
  • [10] Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response
    Reimann, Patrick
    Ulmer, Hanno
    Mutschlechner, Beatrix
    Benda, Magdalena
    Severgnini, Luciano
    Volgger, Andreas
    Lang, Theresia
    Atzl, Michele
    Huynh, Minh
    Gasser, Klaus
    Grabher, Claudia
    Mink, Sylvia
    Fraunberger, Peter
    Petrausch, Ulf
    Hartmann, Bernd
    Winder, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 577 - 584
12345